Leading Element Driving Change in the Zoonotic Disease Treatment Market in 2025: Increased Demand For Animal Proteins Drives Growth In Zoonotic Disease Treatment Market Driver

How Are the key drivers contributing to the expansion of the zoonotic disease treatment market?
The increased demand for animal proteins is expected to propel the growth of the zoonotic disease treatment market. Animal proteins, which include meat, dairy, eggs, and fish, are in higher demand due to factors such as population growth, rising incomes, and increasing awareness of the nutritional benefits of animal-based foods. Zoonotic diseases, which can be transmitted from animals to humans, require effective treatments and preventive measures. According to the Organization for Economic Co-operation and Development and the Food and Agriculture Organization, global meat consumption is expected to grow at an annual rate of 0.1%, driven by rising demand in middle- and lower-income countries. This increasing demand for animal proteins is contributing to the growth of the zoonotic disease treatment market.

Get Your Zoonotic Disease Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

What growth opportunities are expected to drive the zoonotic disease treatment market's CAGR through 2034?
The zoonotic disease treatment market has experienced strong growth in recent years. It is expected to increase from $39.71 billion in 2024 to $42.64 billion in 2025, with a CAGR of 7.4%. The past growth can be attributed to major zoonotic outbreaks, urbanization and habitat encroachment, the adoption of a one-health approach, improved disease surveillance, globalization, increased travel, and greater public awareness and education.

The zoonotic disease treatment market is projected to see significant growth, reaching $55.92 billion by 2029 at a CAGR of 7.0%. Growth in this sector will be driven by climate change and environmental factors, increased government and international funding, technological advancements in medicine, regulatory support for streamlined approvals, and collaborative research and development efforts. Notable trends will include the development of broad-spectrum antivirals, strengthening of global health infrastructure, innovations in diagnostic technology, advancements in vaccine development platforms, and a growing emphasis on preventive healthcare measures.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

What are the emerging trends shaping the future of the zoonotic disease treatment market?
Leading companies in the zoonotic disease treatment market are focusing on advancing diagnostic technologies and improving treatment protocols. This includes developing tools such as PCR kits to rapidly identify zoonotic pathogens and implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, added 13 new members to its Zoonotic Infectious Diseases Total PCR Solution. This expansion aims to enhance diagnostic capabilities for zoonotic diseases, which account for over 60% of known infectious diseases and 75% of emerging infections. This initiative is designed to improve health security and response, especially as climate change contributes to the spread of infectious diseases. By offering quicker diagnoses and better management of zoonotic infections, BioPerfectus aims to strengthen public health efforts.

Which growth-oriented segments of the zoonotic disease treatment market are leading the industry's development?
The zoonotic disease treatment market covered in this report is segmented -

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:
1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment
3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment
6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

What regions are leading the charge in the zoonotic disease treatment market?
North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What companies are at the forefront of innovation in the zoonotic disease treatment market?
Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

What Is Covered In The Zoonotic Disease Treatment Global Market Report?

•Market Size Forecast: Examine the zoonotic disease treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the zoonotic disease treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the zoonotic disease treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the zoonotic disease treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the zoonotic disease treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the zoonotic disease treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the zoonotic disease treatment market.
•Competitive Landscape: Review strategic developments in the zoonotic disease treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.